STOCK TITAN

Allstate Corp SEC Filings

ALL NYSE

Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Allstate Corporation (NYSE: ALL) files a range of documents with the U.S. Securities and Exchange Commission, and this page aggregates those SEC filings for ALL with AI-powered summaries. As a public property and casualty insurer, Allstate uses Form 8-K to report material events such as monthly catastrophe loss estimates, Allstate Protection policies in force, quarterly earnings results, dividend declarations and certain governance changes.

Recent Form 8-K filings show Allstate furnishing monthly releases on catastrophe losses and policy counts for auto, homeowners, other personal lines and commercial lines. These exhibits, referenced under Regulation FD, provide detail on estimated catastrophe losses for specific months and tables of policies in force. Other 8-K filings furnish quarterly earnings press releases and investor supplements, giving investors access to the company’s results of operations and financial condition.

Allstate’s filings also list its registered securities under Section 12(b) of the Exchange Act, including common stock (ALL) and several listed instruments such as 5.100% Fixed-to-Floating Rate Subordinated Debentures due 2053 (ALL.PR.B) and depositary shares representing preferred stock series H, I and J. Filings may also disclose board and governance developments, such as changes in lead director roles and director retirements.

On this SEC filings page, users can review Allstate’s Form 8-K disclosures and, where available, other core filings like annual reports on Form 10-K, quarterly reports on Form 10-Q and proxy statements. AI-generated highlights help explain the key points of lengthy documents, making it easier to understand topics such as catastrophe impacts, policy trends, capital structure and corporate actions without reading every page.

Investors interested in ALL SEC filings can use this resource to track new submissions as they appear on EDGAR, quickly scan AI summaries for each filing and drill into the full text when deeper analysis is needed.

Rhea-AI Summary

A selling stockholder filed a Form 144 to sell up to 33,614 shares of common stock, with an aggregate market value of $6,428,677.5. The notice lists Goldman Sachs & Co. LLC as broker and an approximate sale date of 11/03/2025 on the NYSE.

The seller is identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15. The filing also reports prior sales over the past three months: 16,807 shares on 10/06/2025 for $3,532,582.66 and 16,807 shares on 10/20/2025 for $3,260,884.06.

Context from the notice shows 263,505,334 shares outstanding and indicates portions of the position were originally acquired as compensation via performance awards on 02/22/2018 and 02/08/2019.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Allstate Corp filed a Form 13F reporting its institutional holdings as of the filing period. The report lists 633 portfolio entries with a total market value of $4,381,321,904 and names 2 other included managers.

The filing is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, and identifies the reporting managers as Allstate Investment Management Co and Allstate Investments LLC. This is a routine quarterly holdings disclosure by an institutional manager.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of $193.6903, $194.3583, $195.5023, and $196.5001.

After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Allstate Corporation furnished a Form 8-K under Regulation FD to make available its September 2025 monthly release. The update, posted on allstateinvestors.com and attached as Exhibit 99, announces estimated catastrophe losses and policies in force. The company states the exhibit is furnished and not filed pursuant to Instruction B.2.

This is an informational disclosure intended to provide investors with the latest monthly catastrophe loss estimates and policy counts; specific figures were not included in the excerpt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
current report
-
Rhea-AI Summary

Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported open-market sales executed under a Rule 10b5-1 trading plan adopted on 06/27/2025. On 10/06/2025 he sold a total of 16,807 shares in three reported transactions with weighted average prices of $209.6272, $210.4799, and $211.1514; reported sale price ranges were $209.070$211.280.

After these transactions the reporting person shows 212,040.491 shares held directly and several indirect holdings through trusts and plans totaling 785,718 shares (listed by vehicle). The Form 4 states the sales were effected pursuant to the trading plan and discloses dividend reinvestment activity adding 33.037 shares during April–October 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Mario Rizzo, listed as Chief Operating Officer-AIC of The Allstate Corporation (ALL), reported changes in his beneficial ownership on 10/03/2025 via a Form 4. The filing shows 199 shares acquired upon conversion of a 2022 performance stock award and 89 shares withheld for tax obligations, leaving 68,814 shares reported as directly beneficially owned after the transactions. The report also discloses 1,662 shares held indirectly through a 401(k) plan. In derivative holdings, 224 employee stock options were reported as acquired with an exercise price of $210.82 and an expiration in 2035, and 57 restricted stock units (RSUs) were granted that convert in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The Form is signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Allstate Corporation (ALL) reporting person Jesse E. Merten completed equity transactions tied to long‑term awards and an option exercise in early October 2025. On 10/05/2025 538 shares were acquired on conversion of a 2022 performance stock award and 239 shares were withheld to cover tax obligations related to that conversion. Separately, an employee stock option with a $210.82 exercise price was exercised on 10/03/2025 producing 213 underlying shares, and 54 restricted stock units were granted on 10/03/2025 that vest in three equal increments through 10/03/2028. Following these actions, the reporting person beneficially owned 21,526 shares directly and 7,706 shares indirectly via a 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on 10/03/2025 under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU converts to one share of Allstate common stock without payment on the conversion dates. The RSUs vest in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The reported grant shows 0 purchase price per unit and results in 7,115 shares beneficially owned following the award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Allstate Corporation reported that its Chief Financial Officer, John E. Dugenske, received an award of 4,743 restricted stock units (RSUs) on 10/03/2025 under the 2019 Equity Incentive Plan. Each RSU converts to one share of common stock at no cost to the recipient and the award will vest in three equal installments on 10/03/2026, 10/03/2027, and 10/03/2028. Following the grant, Mr. Dugenske beneficially owns 4,743 shares tied to these RSUs. The Form 4 filing was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE. The filing shows the shares were acquired as performance-award compensation on 02/17/2022 (18,989 shares), 02/18/2021 (11,536 shares) and 02/08/2019 (3,089 shares). The table lists an aggregate market value of $7,019,611.62 and a total outstanding share count of 263,505,334. No sales by the reporting person in the prior three months are reported. The filer certifies they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
other

FAQ

What is the current stock price of Allstate (ALL)?

The current stock price of Allstate (ALL) is $214.52 as of February 27, 2026.

What is the market cap of Allstate (ALL)?

The market cap of Allstate (ALL) is approximately 55.3B.

ALL Rankings

ALL Stock Data

55.34B
258.50M
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
NORTHBROOK

ALL RSS Feed